+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cell Therapy Technologies Market Outlook ]2020-2030

  • PDF Icon

    Report

  • 212 Pages
  • December 2021
  • Region: Global
  • Research Nester Pvt. Ltd
  • ID: 5559849

Global Cell Therapy Technologies Market Analysis 2020-2030


Cell therapy technologies facilitate the transplantation of human cells to replace or repair damaged tissue and cells. The global cell therapy technologies market is anticipated to grow with a CAGR of 13.6% over the forecast period, i.e., 2021 - 2030. Factors such as the growing incidences of chronic diseases around the globe, followed by the rising geriatric population, and therefore the concern for diseases amongst this age groups, are some of the major factors anticipated to drive the market growth. Moreover, factors such as the growing research and developments in the field of cell-based immunotherapies, such as CAR-T therapy, and the rising need for newer, better therapies for diseases, such as cancer and cardiovascular diseases (CVDs) among others, are also expected to drive the market growth during the forecast period. The global cell therapy technologies market is estimated to garner a revenue of around USD 45750 Million by the end of 2030, up from a revenue of over USD 12900 Million in the year 2020.

The global cell therapy technologies market is segmented into numerous segments, which include segmentation by product, process, cell type, end-user, and by region. By product, the market is segmented into consumables, system & software, and equipment. Amongst these, the consumables segment is anticipated to garner the largest revenue of near to USD 17890 Million by the end of 2030. Additionally, the segment generated a revenue of close to USD 5160 Million in the year 2020.

Geographically, the global cell therapy technologies market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Amongst these, the market in North America region is anticipated to garner the largest revenue of more than USD 19950 Million by the end of 2030, up from a revenue of around USD 5800 Million in the year 2020.

Some of the prominent industry leaders in the global cell therapy technologies market that are included in our report are Lonza Group Ltd., Sartorius AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Avantor, Inc., Eppendorf SE, Miltenyi Biotec B.V. & Co. KG, and others.

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Assumptions
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary - Global Cell Therapy Technologies Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities7. Major Roadblocks for the Market Growth8. Regulatory and Standards Landscape9. Industry Risk Analysis10. Pricing Analysis of Cell therapy Technologies Market11. Value Chain Analysis12. Impact of COVID-19 on the Cell Therapy Technologies Market13. Market Share Analysis Based on Therapy14. Competitive Positioning
15. Competitive Landscape
15.1. Market Share Analysis, 2020
15.2. Competitive Benchmarking
15.3. Company Profiles
15.3.1. Lonza Group Ltd.
15.3.2. Sartorius AG
15.3.3. Danaher Corporation
15.3.4. Becton
15.3.5. Dickinson and Company
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. Avantor, Inc.
15.3.8. Eppendorf SE
15.3.9. Miltenyi Biotec B.V. & Co. KG
16. KOL Mapping17. Bioreactors Market Analysis w.r.t. Product, Region, and Year18. Future Forecast of the Manufactures and Startup Companies
19. Global Cell Therapy Technologies Market 2020-2030
19.1. Market Overview
19.2. By Value (USD Million)
20. Global Cell Therapy Technologies Market - Segmentation analysis 2020-2030
20.1. Product
20.1.1. Consumables, 2020-2030F (USD Million)
20.1.2. System & Software, 2020-2030F (USD Million)
20.1.3. Equipment, 2020-2030F (USD Million)
20.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)
20.1.3.2. Single-Use Equipment, 2020-2030F (USD Million)
20.1.3.3. Other Cell Therapy Equipment, 2020-2030F (USD Million)
20.2. Process
20.2.1. Process Monitoring and Quality Control, 2020-2030F (USD Million)
20.2.2. Cell Processing, 2020-2030F (USD Million)
20.2.3. Cell Preservation, distribution and Handling, 2020-2030F (USD Million)
20.3. Cell Type
20.3.1. T-Cells, 2020-2030F (USD Million)
20.3.2. Stem Cells, 2020-2030F (USD Million)
20.3.3. Other Cells, 2020-2030F (USD Million)
20.4. End-User
20.4.1. Contract Research Organizations (CROs), 2020-2030F (USD Million)
20.4.2. Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)
20.4.3. Cell banks, 2020-2030F (USD Million)
20.4.4. Research institutes, 2020-2030F (USD Million)
20.4.5. Other End-Users, 2020-2030F (USD Million)
20.5. Region
20.5.1. North America, 2020-2030F (USD Million)
20.5.2. Europe, 2020-2030F (USD Million)
20.5.3. Asia Pacific, 2020-2030F (USD Million)
20.5.4. Latin America, 2020-2030F (USD Million)
20.5.5. Middle East & Africa, 2020-2030F (USD Million)
21. North America Therapy Technologies Market - Segmentation analysis 2020-2030
21.1. Product
21.1.1. Consumables, 2020-2030F (USD Million)
21.1.2. System & Software, 2020-2030F (USD Million)
21.1.3. Equipment, 2020-2030F (USD Million)
21.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)
21.1.3.2. Single-Use Equipment, 2020-2030F (USD Million)
21.1.3.3. Other Cell Therapy Equipment, 2020-2030F (USD Million)
21.2. Process
21.2.1. Process Monitoring and Quality Control, 2020-2030F (USD Million)
21.2.2. Cell Processing, 2020-2030F (USD Million)
21.2.3. Cell Preservation, distribution and Handling, 2020-2030F (USD Million)
21.3. Cell Type
21.3.1. T-Cells, 2020-2030F (USD Million)
21.3.2. Stem Cells, 2020-2030F (USD Million)
21.3.3. Other Cells, 2020-2030F (USD Million)
21.4. End-User
21.4.1. Contract Research Organizations (CROs), 2020-2030F (USD Million)
21.4.2. Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)
21.4.3. Cell banks, 2020-2030F (USD Million)
21.4.4. Research institutes, 2020-2030F (USD Million)
21.4.5. Other End-Users, 2020-2030F (USD Million)
21.5. Country
21.5.1. United States, 2020-2030F (USD Million)
21.5.2. Canada, 2020-2030F (USD Million)
22. Europe Therapy Technologies Market - Segmentation analysis 2020-2030
22.1. Product
22.2. Process
22.3. Cell-Type
22.4. End-User
22.5. Country
22.5.1. Germany
22.5.2. United Kingdom
22.5.3. France
22.5.4. Italy
22.5.5. Spain
22.5.6. Russia
22.5.7. Netherland
22.5.8. Rest of Europe
23. Asia Pacific Technologies Market - Segmentation analysis 2020-2030
23.1. Product
23.2. Process
23.3. Cell-Type
23.4. End-User
23.5. Country
23.5.1. China
23.5.2. India
23.5.3. Japan
23.5.4. South Korea
23.5.5. Australia
23.5.6. Singapore
23.5.7. Rest of APAC
24. Latin America Technologies Market - Segmentation analysis 2020-2030
24.1. Product
24.2. Process
24.3. Cell-Type
24.4. End-User
24.5. Country
24.5.1. Brazil
24.5.2. Argentina
24.5.3. Mexico
24.5.4. Rest of LATAM
25. Middle East & Africa Technologies Market - Segmentation analysis 2020-2030
25.1. Product
25.2. Process
25.3. Cell-Type
25.4. End-User
25.5. Country
25.5.1. GCC
25.5.2. Israel
25.5.3. South Africa
25.5.4. Rest of MEA

Companies Mentioned

  • Lonza Group Ltd.
  • Sartorius AG
  • Danaher Corporation
  • Becton
  • Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Avantor Inc.
  • Eppendorf SE
  • Miltenyi Biotec B.V. & Co. KG